Financials
- Market Capitalization 453.82 M
- Employee 9
- Founded 2000
- CEO N/A
- Website www.galectintherapeutics.com
- Headquarter Nevada, United States
- FIGI BBG000BK6FP5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.79
市销率
-65.57
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2977 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.71 USD | +4.01% | +3.63% | +20.72% | +77.88% | 457.97 M USD | ||
| 2978 | EVMN Evommune, Inc. Common Stock | 12.50 USD | +0.08% | -10.65% | +12.21% | -27.83% | 453.65 M USD | ||
| 2986 | OCGN Ocugen, Inc. - Common Stock | 1.33 USD | 0.00% | -5.67% | +7.26% | +31.68% | 451.02 M USD | ||
| 2995 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 7.04 USD | +1.44% | -3.69% | -13.19% | -20.72% | 452.96 M USD |